arrow
M

Matthew Greenhawt

aquestive therapeutics
H指数:69
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation and reliability of the Italian versions of the Food Allergy Quality of Life -Parental Burden (FAQL-PB) and -Parent Form 10 (FAQLQ-PF10) Questionnaires

意大利版食物过敏生活质量问卷-家长负担量表(FAQL-PB)和-家长形式10(FAQLQ-PF10)的效度和信度验证

2026-10-030
OAAI
Vaccines, Bias, and the Perils of Non-peer-reviewed Studies: Fueling Misinformation and Vaccine Hesitancy

疫苗、偏见与非同行评审研究的危害:助长错误信息与疫苗犹豫

2026-08-050
OAAI
‘What’ and ‘How’ to Measure in Allergy and Clinical Immunology: A Systematic Review of Core Outcome Sets and Outcome Harmonisation Processes

在变态反应与临床免疫学中测量‘什么’和‘如何’:核心结局指标集和结局指标协调过程的系统综述

2026-04-130
OAAI
Efficacy and Safety of Ligelizumab in Individuals With Confirmed Peanut Allergy

Ligelizumab在确认花生过敏的个体中的疗效和安全性

2026-01-200
PRE
Epinephrine and Emergency Medical Services Activation Recommendations During Acute Allergic Reactions in Community Settings: International Consensus Report

急性过敏反应期间肾上腺素和急救医疗服务启动建议:社区环境国际共识报告

2025-12-100
PRE
Change, Career Transitions, and Retirement in Allergy-Immunology

变化、职业转型与过敏-免疫学领域的退休

2025-11-260
PRE
Addressing Anxiety and Depression in the Allergy Clinic Through Motivational Interviewing, Brief Cognitive Behavioral Therapy, and Curious Questions

通过动机性访谈、简短认知行为疗法和好奇提问解决过敏诊所中的焦虑和抑郁问题

2025-05-160
PRE
Patient-Reported Outcomes on Food Immunotherapy Differ Between Countries and Foods: Results From COFAITH

不同国家和食物的食品免疫疗法患者报告结局存在差异:COFAITH研究的结果

2025-05-080
PRE
Development of a validated, updated North American pediatric food allergy anaphylaxis management plan

开发并验证更新的北美儿科食物过敏性过敏性休克管理计划

2025-04-140
PRE
Cost-effectiveness of shared decision-making in determining challenge setting for nonsevere food protein-induced enterocolitis syndrome

共享决策在确定非严重食物蛋白诱导性小肠结肠炎综合征挑战设置中的成本效益

2025-03-150
PRE